Ventas Stock Rallies 24.8% in Six Months: Will the Momentum Last?
AI Sentiment
Highly Positive
9/10
as of 03-09-2026 1:58pm EST
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 41.1B | IPO Year: | 2005 |
| Target Price: | $84.77 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | annual | |
| EPS: | 0.54 | EPS Growth: | 184.21 |
| 52 Week Low/High: | $60.15 - $87.87 | Next Earning Date: | 05-05-2026 |
| Revenue: | $5,833,980,000 | Revenue Growth: | 18.47% |
| Revenue Growth (this year): | 12.42% | Revenue Growth (next year): | 8.32% |
| P/E Ratio: | 157.17 | Index: | |
| Free Cash Flow: | 1.5B | FCF Growth: | N/A |
EVP and GC
Avg Cost/Share
$85.00
Shares
35,532
Total Value
$3,020,116.96
Owned After
72,755
SEC Form 4
Chairman and CEO
Avg Cost/Share
$82.23
Shares
10,322
Total Value
$848,751.22
Owned After
1,114,034
SEC Form 4
Chairman and CEO
Avg Cost/Share
$77.66
Shares
10,322
Total Value
$801,605.49
Owned After
1,114,034
SEC Form 4
EVP and CFO
Avg Cost/Share
$77.25
Shares
29,930
Total Value
$2,312,188.28
Owned After
138,434
SEC Form 4
Chairman and CEO
Avg Cost/Share
$77.26
Shares
10,322
Total Value
$797,474.62
Owned After
1,114,034
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Roberts Carey S. | VTR | EVP and GC | Feb 11, 2026 | Sell | $85.00 | 35,532 | $3,020,116.96 | 72,755 | |
| CAFARO DEBRA A | VTR | Chairman and CEO | Feb 6, 2026 | Sell | $82.23 | 10,322 | $848,751.22 | 1,114,034 | |
| CAFARO DEBRA A | VTR | Chairman and CEO | Feb 2, 2026 | Sell | $77.66 | 10,322 | $801,605.49 | 1,114,034 | |
| Probst Robert F | VTR | EVP and CFO | Jan 2, 2026 | Sell | $77.25 | 29,930 | $2,312,188.28 | 138,434 | |
| CAFARO DEBRA A | VTR | Chairman and CEO | Jan 2, 2026 | Sell | $77.26 | 10,322 | $797,474.62 | 1,114,034 |
SEC 8-K filings with transcript text
Feb 5, 2026 · 100% conf.
1D
+2.81%
$82.08
Act: +3.39%
5D
+6.61%
$85.12
Act: +6.71%
20D
+5.90%
$84.55
Act: +6.30%
vtr-202602050000740260FALSE00007402602026-02-052026-02-050000740260exch:XNYS2026-02-052026-02-05
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2026
Ventas, Inc. (Exact name of registrant as specified in its charter)
Delaware 001-10989 61-1055020 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
300 North LaSalle Street, Suite 1600, Chicago, Illinois 60654 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (877) 483-6827
Not applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.25 par valueVTRNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On February 5, 2026, Ventas, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter and year ended December 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Item 2.02 by reference. The information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description 99.1 Press release issued by the Company on February 5, 2026.
104Cover Page Interactive Data File (formatted as inline XBRL).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 5, 2026 By: /s/ Carey S. Roberts Carey S. Roberts Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary
Oct 29, 2025
vtr-202510290000740260FALSE300 North LaSalle Street, Suite 1600ChicagoIllinois00007402602025-10-292025-10-290000740260exch:XNYS2025-10-292025-10-29
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 29, 2025
Ventas, Inc. (Exact name of registrant as specified in its charter)
Delaware 001-10989 61-1055020 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
300 North LaSalle Street, Suite 1600, Chicago, Illinois 60654 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (877) 483-6827
Not applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.25 par valueVTRNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On October 29, 2025, Ventas, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Item 2.02 by reference. The information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description 99.1 Press release issued by the Company on October 29, 2025.
104Cover Page Interactive Data File (formatted as inline XBRL).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 29, 2025 By: /s/ Carey S. Roberts Carey S. Roberts Executive Vice President, General Counsel, Ethics and Compliance Officer and Corporate Secretary
Jul 30, 2025
vtr-202507300000740260FALSE00007402602025-07-302025-07-300000740260exch:XNYS2025-07-302025-07-30
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2025
Ventas, Inc. (Exact name of registrant as specified in its charter)
Delaware 001-10989 61-1055020 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
300 North LaSalle Street, Suite 1600, Chicago, Illinois 60654 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (877) 483-6827
Not applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.25 par valueVTRNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On July 30, 2025, Ventas, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Item 2.02 by reference. The information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description 99.1 Press release issued by the Company on July 30, 2025.
104Cover Page Interactive Data File (formatted as inline XBRL).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 30, 2025 By: /s/ Carey S. Roberts Carey S. Roberts Executive Vice President, General Counsel, Ethics and Compliance Officer and Corporate Secretary
VTR Breaking Stock News: Dive into VTR Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
9/10
AI Sentiment
Positive
6/10
See how VTR stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "VTR Ventas Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.